Telefónica Circles Mexican Rival

Related Link: 

Telefónica said it is in talks to buy a Mexican rival, reported to be Iusacell, in a deal that could be worth as much as $4 billion.

GM to Start Taking Crash Claims

Related Link: 

General Motors on Friday starts taking applications from victims of accidents involving defective ignition switches in its small cars, promising the first payouts from the about $400 million fund by November.

Mixed Fortunes for European Car Makers

Related Link: 

European car makers painted a murky portrait of the global auto industry as concerns about Russia and Latin America blunt the optimism fueled by a steady rebound in European auto demand.

Boeing to Build New 787 Dreamliner in S. Carolina

Related Link: 

Boeing plans to build a new version of its flagship 787 Dreamliner jet exclusively at its nonunion factory in South Carolina.

Drug Firms Buy $67.5 Million Voucher to Speed FDA Review

Related Link: 

Regeneron Pharmaceuticals and Sanofi are spending $67.5 million to buy a special voucher held by BioMarin Pharmaceuticals in a bid to hasten regulatory review of their new cholesterol drug.

Global Firms See Risks in Russia

Related Link: 

U.S. and European companies are girding for the possible impact of tougher international sanctions against Moscow, with auto makers and energy giants moving to limit the Russia risks to their businesses.

FCC Questions Verizon Data-Speed Plan

Related Link: 

The FCC took issue with Verizon's plan to reduce speeds for heavy data users on unlimited data plans at times of high demand.

Insurers Post Lackluster Results

Related Link: 

MetLife, Allstate and Hartford Financial reported lackluster operating earnings for the second quarter, in part due to higher storm and catastrophe-related property claims.

Barclays Under U.S. Pressure

Related Link: 

Barclays swung to a net profit in the second quarter but is under renewed pressure in the U.S. after authorities extended a nonprosecution agreement to cover a probe into alleged foreign-exchange manipulation.

Teva Shareholders Back Directors Targeted by Dissidents

Related Link: 

Shareholders of Teva Pharmaceutical Industries voted in favor of all of management's proposals at the company's annual meeting, the Israeli drug maker said Wednesday.

Syndicate content